Abstract

BackgroundGenome-wide association studies (GWAS) have been used successfully in detecting associations between common genetic variants and complex diseases. However, common SNPs detected by current GWAS only explain a small proportion of heritable variability. With the development of next-generation sequencing technologies, researchers find more and more evidence to support the role played by rare variants in heritable variability. However, rare and common variants are often studied separately. The objective of this paper is to develop a robust strategy to analyze association between complex traits and genetic regions using both common and rare variants.ResultsWe propose a weighted selective collapsing strategy for both candidate gene studies and genome-wide association scans. The strategy considers genetic information from both common and rare variants, selectively collapses all variants in a given region by a forward selection procedure, and uses an adaptive weight to favor more likely causal rare variants. Under this strategy, two tests are proposed. One test denoted by BwSC is sensitive to the directions of genetic effects, and it separates the deleterious and protective effects into two components. Another denoted by BwSCd is robust in the directions of genetic effects, and it considers the difference of the two components. In our simulation studies, BwSC achieves a higher power when the casual variants have the same genetic effect, while BwSCd is as powerful as several existing tests when a mixed genetic effect exists. Both of the proposed tests work well with and without the existence of genetic effects from common variants.ConclusionsTwo tests using a weighted selective collapsing strategy provide potentially powerful methods for association studies of sequencing data. The tests have a higher power when both common and rare variants contribute to the heritable variability and the effect of common variants is not strong enough to be detected by traditional methods. Our simulation studies have demonstrated a substantially higher power for both tests in all scenarios regardless whether the common SNPs are associated with the trait or not.

Highlights

  • Genome-wide association studies (GWAS) have been used successfully in detecting associations between common genetic variants and complex diseases

  • The analysis of accumulative effect of rare variants may become crucial in discovering the link between a candidate gene and the heritable variability missed by the traditional GWAS

  • Genetic effect parameters OR for eight rare variants are listed in the table

Read more

Summary

Introduction

Genome-wide association studies (GWAS) have been used successfully in detecting associations between common genetic variants and complex diseases. With the development of next-generation sequencing technologies, researchers find more and more evidence to support the role played by rare variants in heritable variability. Common SNPs detected by current GWAS only explain a small proportion of heritable variability [1] These identified common SNPs usually have a relatively small to modest genetic effect, which suggests that another type of variants, rare variants, need to be considered in the current GWAS. In addition to the Common Diseases Common Variants (CDCV) hypothesis underlying complex-disease etiology, an alternative hypothesis, the Common Diseases Rare Variants (CDRV) hypothesis has been the topic of much recent debate [4] Under this hypothesis, the analysis of accumulative effect of rare variants may become crucial in discovering the link between a candidate gene and the heritable variability missed by the traditional GWAS. The development of more powerful statistical tests for association studies using both rare and common variants is needed to meet these challenges

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call